NASDAQ:RGEN
Repligen Corporation Stock News
$167.05
+0.740 (+0.445%)
At Close: May 03, 2024
Despite Attractive End Markets, Analyst Outlines Concerns For Repligen Stock
06:40pm, Wednesday, 07'th Dec 2022 Benzinga
RBC Capital Markets has initiated coverage on Repligen Corporation (NASDAQ: RGEN) with a Sector Perform rating and a price target of $190.
The analyst likes the company due to product differentiat
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
04:31pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?
04:31pm, Thursday, 01'st Dec 2022 Zacks Investment Research
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?
12:48pm, Thursday, 01'st Dec 2022
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
BIIB or RGEN: Which Is the Better Value Stock Right Now?
04:40pm, Wednesday, 23'rd Nov 2022 Zacks Investment Research
BIIB vs. RGEN: Which Stock Is the Better Value Option?
BIIB or RGEN: Which Is the Better Value Stock Right Now?
12:48pm, Wednesday, 23'rd Nov 2022
BIIB vs. RGEN: Which Stock Is the Better Value Option?
BIIB vs. RGEN: Which Stock Is the Better Value Option?
12:49pm, Monday, 07'th Nov 2022
BIIB vs. RGEN: Which Stock Is the Better Value Option?
Repligen (RGEN) Beats Q3 Earnings Estimate, Ups 2022 Guidance
04:30pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Repligen (RGEN) reports encouraging third-quarter results, with sales and earnings beating estimates. RGEN also raises its financial guidance for 2022
Repligen (RGEN) Q3 Earnings and Revenues Top Estimates
12:45pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Repligen (RGEN) delivered earnings and revenue surprises of 13.24% and 4.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
11:30am, Tuesday, 01'st Nov 2022 GlobeNewswire Inc.
WALTHAM, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its
Repligen (RGEN) Q3 Earnings and Revenues Top Estimates
09:47am, Tuesday, 01'st Nov 2022
Repligen (RGEN) delivered earnings and revenue surprises of 13.24% and 4.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
04:10pm, Monday, 31'st Oct 2022 Zacks Investment Research
Repligen (RGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Monday, 31'st Oct 2022
Repligen (RGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Gritstone bio Inc. (GRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LGND vs. RGEN: Which Stock Is the Better Value Option?
03:40pm, Friday, 21'st Oct 2022 Zacks Investment Research
LGND vs. RGEN: Which Stock Is the Better Value Option?
